Grants and Contributions:
Title:
COVID-19 Response - Rapid Test for Detection of Total SARS-CoV2 Antibodies
Agreement Number:
949130
Agreement Value:
$703,750.00
Agreement Date:
May 1, 2020 - Mar 31, 2021
Description:
This project will support the firm to design, develop and validate a one-minute test for the qualitative detection of total SARS-CoV2 antibodies in human fingerstick blood, to be used as a self-test and/or at the point of care. It is anticipated that the test could be used for multiple purposes, including for serosurveillance of populations or as an aid in diagnosis of SARS-CoV2 infection in conjunction with clinical presentation and the results of other tests.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Richmond, British Columbia, CA V6V 2A2
Reference Number:
172-2020-2021-Q1-949130
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
869859116
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 70,000 dollars.
Amendment Date
Mar 8, 2021
Recipient's Legal Name:
BioLytical Laboratories Inc.
Federal Riding Name:
Steveston--Richmond East
Federal Riding Number:
59031
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: